Spike protein found persisting in blood vessels for years after COVID infection
Long COVID research had a busy week, and the findings are getting harder to dismiss as post-viral noise.
From blood vessels scarring around lingering spike protein to a fat metabolism signal that predicts who gets sick, the biology is getting more specific—and more uncomfortable.
The spike protein may be sticking around—and remodeling your blood vessels 🔬
- In both people who died from COVID-19 and people living with long COVID symptoms for up to five years, researchers found spike protein still present in the microvasculature—the tiny blood vessels in the brain and skin.
- The density of a key receptor (the one the virus docks onto) was roughly 6x higher in long COVID cases than in people who fully recovered. In mice exposed to spike protein for 1.5 months, that same receptor density jumped 19-fold compared to early exposure.
- Critically, collagen buildup around those vessels—a sign of scarring and restricted blood flow—appeared only in fatal COVID cases, long COVID cases, and the longer-exposure mice. Not in recovered patients, not in short-exposure mice.
Why it matters: This is observational and cross-species, so causation isn't established. But the pattern across humans and mice suggests persistent spike exposure may drive a slow-moving vascular injury process, not just an acute inflammatory spike.
Key Findings
A fat metabolism signal predicts long COVID—before symptoms lock in 🧪
- Tracking plasma samples from 106 people across the 12 months after infection, researchers found that elevated activity in a specific fat-processing pathway (lipoxygenase-driven metabolism of dietary fatty acids) during the acute phase was associated with later development of long COVID.
- In the months that followed, long COVID participants showed a progressive uncoupling of these lipid pathways compared to people who recovered—suggesting the disruption isn't just acute but ongoing.
Sleep apnea is twice as common in long COVID fatigue patients—but isn't explaining their symptoms
- Among 100 long COVID patients reporting fatigue (average age 46, 70% female), 53% had obstructive sleep apnea on home sleep testing—roughly double the general adult rate in the US.
- Despite that prevalence, sleep apnea severity was not a significant predictor of cognitive function or quality of life. The fatigue and brain fog appear to have a different driver.
Abnormal protein modifications in blood may distinguish three overlapping post-viral conditions
- A preliminary study found that post-translational modifications in the insoluble fraction of platelet-poor plasma could differentiate pre-COVID postural tachycardia syndrome, long COVID with orthostatic hypotension, and long COVID-associated postural tachycardia syndrome—conditions that look nearly identical on routine labs.
- The findings build on prior work identifying amyloid-like microclot complexes in long COVID, suggesting protein-level blood abnormalities may be a distinguishing feature across related post-viral syndromes.
Patients with long COVID are becoming their own diagnostic experts—because they have to
- A qualitative analysis of over 400 clinical encounter accounts and 100 patient testimonies found that long COVID patients frequently faced symptom minimization, psychosocial reframing, and fragmented care pathways.
- In response, many developed deep biomedical literacy and formed collective knowledge networks—what the researchers call "expert patients"—to navigate systems that weren't recognizing their illness.
Brain changes in long COVID are real—and recurrent across 42 studies 🧠
- A systematic review of 42 studies found consistent patterns of altered cortical excitability, abnormal brain oscillations, changed functional connectivity, and structural changes in neural networks among long COVID patients.
- Some studies also flagged biomarkers suggesting neuroinflammation or axonal injury. These changes tracked with fatigue, cognitive dysfunction, and brain fog—but the evidence base is limited by inconsistent methods across studies.
Post-exertional malaise is a defining long COVID symptom—and primary care is underprepared
- A clinical review highlights post-exertional malaise (PEM)—symptom worsening after physical, cognitive, or emotional effort—as a hallmark feature of long COVID and related post-infectious syndromes, first described in chronic fatigue syndrome.
- Early identification matters: without appropriate management, PEM is associated with long-term functional decline. Current primary care guidance on recognition and pacing strategies remains limited.
Implications
The week's evidence keeps pointing the same direction: long COVID involves measurable, persistent biological disruption—in blood vessels, lipid pathways, brain activity, and blood proteins. The unresolved tension is whether the vascular scarring and spike persistence observed here represent a reversible process or a self-sustaining injury loop that treatment windows can't easily reach.
Studies in this issue
Primary sources used for this newsletter.
- Effects of Long-Term Exposure to the COVID-19 Spike Protein in Long COVID and a Mouse Modelmain storyThe American journal of pathology2026-10-20PMID 42901242
- Obstructive sleep apnea is common in Long COVID fatigue but is not strongly linked to changes in quality of life or thinking skillskey findingGeroScience2026-10-20PMID 42897409
- Long COVID is linked to changes in essential fatty acid breakdown by lipoxygenasekey findingiScience2026-10-23PMID 42909166
- Changes in the Nervous System in People with Long COVID: A Systematic Reviewkey findingRevista da Sociedade Brasileira de Medicina Tropical2026-10-23PMID 42912090
- Understanding Long COVID: Challenges in Recognition and Carekey findingJournal of primary care & community health2026-10-22PMID 42902825
- Identifying and treating extreme tiredness after exercise in primary carekey findingRevue medicale suisse2026-10-20PMID 42899626
- Protein changes in blood plasma help distinguish pre-COVID postural orthostatic tachycardia syndrome, Long COVID, and Long COVID with POTS: a preliminary studykey findingCardiovascular diabetology2026-10-20PMID 42897639
Continue reading
All Long Covid issuesGet the next Long Covid issue
Seven papers, once a week. Free.